Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency
Authors:
- 25 January 2022
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 135 (3) , 186-192
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiencyMolecular Genetics and Metabolism, 2021
- A three-tier algorithm for guanidinoacetate methyltransferase (GAMT) deficiency newborn screeningMolecular Genetics and Metabolism, 2016
- Guanidinoacetate methyltransferase (GAMT) deficiency: Outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoringMolecular Genetics and Metabolism, 2014
- Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiencyJournal of Inherited Metabolic Disease, 2013
- Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiencyMolecular Genetics and Metabolism, 2013
- Regulation of respiration in brain mitochondria and synaptosomes: restrictions of ADP diffusion in situ, roles of tubulin, and mitochondrial creatine kinaseMolecular and Cellular Biochemistry, 2008
- Pre-Symptomatic Treatment of Creatine Biosynthesis Defects2007
- Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiencyNeurology, 2006
- Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from NewbornsClinical Chemistry, 2003
- Improving Treatment of Guanidinoacetate Methyltransferase Deficiency: Reduction of Guanidinoacetic Acid in Body Fluids by Arginine Restriction and Ornithine SupplementationMolecular Genetics and Metabolism, 2001